Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
John R Fullarton 2 Articles
IBD
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
Intest Res 2023;21(1):161-167.   Published online April 18, 2022
DOI: https://doi.org/10.5217/ir.2022.00006
PDFSupplementary MaterialPubReaderePub

Citations

Citations to this article as recorded by  
  • New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
    Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim, Jae Hee Cheon
    Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
  • 4,223 View
  • 526 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
IBD
IBD2020 global forum: results of an international patient survey on quality of care
Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis
Intest Res 2018;16(4):537-545.   Published online October 10, 2018
DOI: https://doi.org/10.5217/ir.2018.00041
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
IBD2020 is a global forum for standards of care in inflammatory bowel disease (IBD). The aim of the IBD2020 survey was to identify and describe variations in quality care of IBD.
Methods
Patients with IBD from Finland, Italy, France, Canada, Germany, UK, Spain and Sweden were surveyed during 2013 to 2014, covering: disease characteristics; impact on life and work; organization and perceived quality of care.
Results
Seven thousand five hundred and seven patients participated (median age, 39 years [range, 10–103 years]; 2,354 male [31.4%]), including 4,097 (54.6%) with Crohn’s disease (CD) and 3,410 (45.4%) with ulcerative colitis (UC). Median time from symptom onset to diagnosis was 1 year for both CD (range, 0–47 years) and UC (range, 0–46 years), with no clear evidence of improvement in diagnostic delay over the preceding 24 years. Half of the patients (3,429; 50.0%) rated their care as “excellent” or “very good,” with similar results for CD and UC across countries. Five factors were significantly (P<0.01) associated with perceived good quality of care: quality of specialist communication; review consultation being long enough; failure to share information; no access to a dietician; speed of advice.
Conclusions
The IBD2020 survey has highlighted areas related to quality of care of IBD from the patients’ perspective, with scope for improvement.

Citations

Citations to this article as recorded by  
  • Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study
    Rachel Cooney, Daniel Tang, Kevin Barrett, Richard K Russell
    Inflammatory Bowel Diseases.2024; 30(8): 1264.     CrossRef
  • Impact of mental health comorbidity in children and young adults with inflammatory bowel disease: a UK population-based cohort study
    Rachel Cooney, Kevin Barrett, Richard K Russell
    BMJ Open.2024; 14(2): e080408.     CrossRef
  • Sources of diagnostic delay for people with Crohn’s disease and ulcerative colitis: Qualitative research study
    Valérie Pittet
    PLOS ONE.2024; 19(6): e0301672.     CrossRef
  • Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease
    Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C. Pollok
    Alimentary Pharmacology & Therapeutics.2023; 57(6): 635.     CrossRef
  • Diagnostic delay in adult inflammatory bowel disease: A systematic review
    Eleanor Cross, Benjamin Saunders, Adam D. Farmer, James A. Prior
    Indian Journal of Gastroenterology.2023; 42(1): 40.     CrossRef
  • The Experiences of Older Adults Living With Inflammatory Bowel Disease
    Noelle Rohatinsky, Brooke Russell, Kevin B. Read
    Gastroenterology Nursing.2023; 46(4): 296.     CrossRef
  • Unmet Challenges in Patients with Crohn’s Disease
    Katharina M Scheurlen, Mary A Parks, Anne Macleod, Susan Galandiuk
    Journal of Clinical Medicine.2023; 12(17): 5595.     CrossRef
  • The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
    Holly Mathias, Noelle Rohatinsky, Sanjay K Murthy, Kerri Novak, M Ellen Kuenzig, Geoffrey C Nguyen, Sharyle Fowler, Eric I Benchimol, Stephanie Coward, Gilaad G Kaplan, Joseph W Windsor, Charles N Bernstein, Laura E Targownik, Juan-Nicolás Peña-Sánchez, K
    Journal of the Canadian Association of Gastroenterology.2023; 6(Supplement): S111.     CrossRef
  • Inflammatory bowel diseases: Transformation of representations. A review
    Igor V. Maev, Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva
    Terapevticheskii arkhiv.2023; 95(12): 1064.     CrossRef
  • Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
    Nurulamin M Noor, Paula Sousa, Stéphane Paul, Xavier Roblin
    Inflammatory Bowel Diseases.2022; 28(8): 1254.     CrossRef
  • Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
    Axel U. Dignass, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John R. Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R. Moschen, Neeraj Narula, Grazyna Rydzewska, Simon P. L. Travis
    Scandinavian Journal of Gastroenterology.2022; 57(4): 424.     CrossRef
  • Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients
    A. Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, Rachel Ainley, Ian Arnott, Kevin J. Barrett, Graham Bell, Matthew J. Brookes, Melissa Fletcher, Rafeeq Muhammed, Alan M. Nevill, Jonathan Segal, Christian P. Selinger, Anja St. Clair Jones, Lisa You
    Alimentary Pharmacology & Therapeutics.2022; 56(4): 625.     CrossRef
  • Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain
    Xavier Calvet, Julián Panés, Javier Gallardo-Escudero, Alberto de la Cuadra-Grande, Elena Bartolomé, Laura Marín, Fernando de la Portilla, Ester Navarro-Correal, Ana Gutiérrez, Pilar Nos, Ruth Serrano, Miguel Ángel Casado, Manuel Barreiro-de Acosta, Pilar
    Journal of Crohn's and Colitis.2022; 16(11): 1663.     CrossRef
  • Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care
    Darren Wong, Lawrence Matini, Andrey Kormilitzin, Ramona Kantschuster, Daniel Martin Simadibrata, Sara Lyden, Jean Wilson, Oliver A Brain, Rebecca Palmer, Tim Ambrose, Jack Satsangi, Matthew South, John Geddes, Keith Bodger, Simon P L Travis, Alissa Walsh
    Journal of Crohn's and Colitis.2022; 16(12): 1874.     CrossRef
  • Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
    Debora Mayumi Takamune, Giovana Signorelli Astolfi Cury, Giulia Ferrás, Giedre Soares Prates Herrerias, Adriana Rivera, Jaqueline Ribeiro Barros, Julio Pinheiro Baima, Rogerio Saad-Hossne, Ligia Yukie Sassaki
    World Journal of Clinical Cases.2022; 10(33): 12184.     CrossRef
  • Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians
    David T Rubin, Ailsa Hart, Remo Panaccione, Alessandro Armuzzi, Ulla Suvanto, J Jasper Deuring, John Woolcott, Joseph C Cappelleri, Kathy Steinberg, Laura Wingate, Stefan Schreiber
    Inflammatory Bowel Diseases.2021; 27(7): 1096.     CrossRef
  • The new frontier: Certifying quality standards in the inflammatory bowel disease care
    Gionata Fiorino, Silvio Danese
    United European Gastroenterology Journal.2021; 9(7): 745.     CrossRef
  • Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
    Rukshana Kapasi, Jackie Glatter, Christopher A Lamb, Austin G Acheson, Charles Andrews, Ian D Arnott, Kevin J Barrett, Graham Bell, Guaraang Bhatnagar, Stuart Bloom, Matthew James Brookes, Steven R Brown, Nicola Burch, Andy Burman, Kay Crook, JR Fraser Cu
    Frontline Gastroenterology.2020; 11(3): 178.     CrossRef
  • Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper
    Gionata Fiorino, Theodore Lytras, Lisa Younge, Catarina Fidalgo, Sofie Coenen, Maria Chaparro, Mariangela Allocca, Ian Arnott, Peter Bossuyt, Johan Burisch, Marjo Campmans-Kuijpers, Lissy de Ridder, Axel Dignass, Ciara Drohan, Roger Feakins, Daniela Gilar
    Journal of Crohn's and Colitis.2020; 14(8): 1037.     CrossRef
  • Mejora de la atención al paciente con enfermedad inflamatoria intestinal: Proyecto KOAN
    Jordi Guardiola, Laura Marín, Javier P. Gisbert, Fernando Gomollón, Jordi Cohen, Carmen Conde
    Economía de la Salud.2019;[Epub]     CrossRef
  • 8,118 View
  • 198 Download
  • 19 Web of Science
  • 20 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP